Paradigm Capital Management Inc’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
AC
RA
BH
WCM
Paradigm Capital Management Inc's ANGO Position: Q2 2026 in Review
Paradigm Capital Management Inc reduced its AngioDynamics (ANGO) stake by 6.5% in Q2 2026, selling an estimated $535K and leaving 671,200 shares worth $8.73M. The position accounts for 0.24% of the portfolio, ranked #54.
Paradigm Capital Management Inc first reported a position in ANGO in Q2 2014 and has held it in 22 quarters since. The position peaked at $9.09M in Q2 2014. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- Paradigm Capital Management Inc held 671,200 shares of AngioDynamics worth $8.73M as of Q2 2026.
- Paradigm Capital Management Inc sold 47,000 AngioDynamics shares in Q2 2026, an estimated $535K.
- AngioDynamics made up 0.24% of Paradigm Capital Management Inc's portfolio in Q2 2026, its #54 holding.
- Paradigm Capital Management Inc first reported a position in AngioDynamics in Q2 2014 and has held it in 22 quarters since.
- Paradigm Capital Management Inc's AngioDynamics position peaked at $9.09M in Q2 2014.
- 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on Paradigm Capital Management Inc's 13F filing for Q2 2026, filed 13 Aug 2026.